Andrew R. Melville
Glasgow, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Biologic and targeted synthetic DMARD safety in inflammatory arthritis: British Society for Rheumatology guideline scope.
Journal: Rheumatology advances in practice
Published: June 26, 2025
Clinical predictors of flare and drug-free remission in rheumatoid arthritis: preliminary results from the prospective BIO-FLARE experimental medicine study.
Journal: BMJ open
Published: April 09, 2025
Neither ultrasound synovitis nor clinical-ultrasound phenotypes of established rheumatoid arthritis predict response to targeted therapy.
Journal: Rheumatology (Oxford, England)
Published: March 05, 2025
Single-centre experience of refractory rheumatoid arthritis.
Journal: Rheumatology advances in practice
Published: April 07, 2022
Real-world experience of effectiveness of non-medical switch from originator to biosimilar rituximab in rheumatoid arthritis.
Journal: Rheumatology (Oxford, England)
Published: August 17, 2020
Real-world single centre use of JAK inhibitors across the rheumatoid arthritis pathway.
Journal: Rheumatology (Oxford, England)
Published: August 03, 2020
Understanding Refractory Rheumatoid Arthritis: Implications for a Therapeutic Approach.
Journal: Drugs
Published: May 04, 2020
'Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients'.
Journal: Annals of the rheumatic diseases
Published: June 12, 2019
Synovial Tissue Heterogeneity in Rheumatoid Arthritis and Changes With Biologic and Targeted Synthetic Therapies to Inform Stratified Therapy.
Journal: Frontiers in medicine
Published: December 14, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026